In 2007, eleven major U.S. research universities and the Association of American Medical Colleges signed an accord titled In the Public Interest: Nine Points to Consider in Licensing University Technology. It outlined a range of issues that universities should consider when licensing their technology to the private sector—from reservations of rights and limitations on exclusivity to limiting dealings with patent assertion entities to making medical technologies accessible at affordable prices. More than talking points, the document proposed specific contractual clauses intended to promote the educational and public welfare missions of universities. Today, more than a hundred academic institutions and associations around the world have signed the Nine Points document. Yet in the fifteen years since the document was created, there has been no systematic, empirical assessment of its effect on university licensing practices. This Article fills that gap with the first empirical study of the impact of the Nine Points document on university licensing practices. Through a review of 220 publicly available university technology licenses signed both before and after the adoption of the Nine Points document, this Article finds that while the document prompted the expansion of educational and non-profit research using patented university technology, it resulted in few changes relating to the promotion of public health or access to medical technologies. This mixed adoption of the recommendations made by the Nine Points document suggests that there is little consensus regarding the nature of the ‘public interest’ that the Nine Points document sought to promote. This Article recommends that a reorientation of university technology transfer policy may be in order—one that could be facilitated through greater engagement of academic faculty, senior administrators, students, alumni, and other institutional stakeholders in setting policy for university technology transfer.